Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 22, 2024 10:02 ET | Source: Research and Markets

Global Vitamin D (D2, D3) Ingredients Market Analysis Report 2023: Market to Grow by Over $1 Billion During 2022-2029 - Increased Fortification in Food and Beverage Industries Fueling Growth

Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Vitamin D Ingredients Market (2023 Edition): Analysis By Product Type (Vitamin D2, Vitamin D3), By Source, By Application, By Region, By...
January 17, 2023 07:00 ET | Source: Meticulous Market Research Pvt. Ltd.

Vitamin D Market Worth $2.43 Billion by 2030 - Exclusive Report by Meticulous Research®

Redding, California, Jan. 17, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Vitamin D Market by Analog (Vitamin D3, Vitamin D2), Source (Plant-sourced,...
October 06, 2016 12:52 ET | Source: Entia Biosciences, Inc.

Entia Biosciences, Inc. (OTCQB: ERGO) to Present Results of Chronic Kidney Disease Medical Food Clinical Study at American Society of Nephrology / Kidney Week 2016 Annual Meeting

PORTLAND, Ore., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) was informed by the American Society of Nephrology (“ASN”) that its submission of “late breaking clinical...
December 21, 2015 15:12 ET | Source: Entia Biosciences, Inc.

UPDATE -- Entia Biosciences, Inc. Begins Clinical Study of Proprietary ErgoD2® Medical Food Product to Demonstrate Improved Health for the More Than 25 Million Chronic Kidney Disease Sufferers in the U.S.

PORTLAND, Ore., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported greater-than-expected...
December 21, 2015 08:50 ET | Source: Entia Biosciences, Inc.

Entia Biosciences, Inc. Begins Clinical Study of Proprietary ErgoD2® Medical Food Product to Demonstrate Improved Health for the More Than 25 Million Chronic Kidney Disease Sufferers in the U.S.

PORTLAND, Ore., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported greater-than-expected...